mdco-2010
Small moleculeexperimental
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Nov 1, 2010 (NCT01535222)
Timeline
2010s
- Jan 1, 2010
Earliest Phase 2 Sponsor(trial)
Indications
Mechanism of action
- ThrombinINHIBITOR
F2 inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- mdco-2010
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01530399 | Phase 2 | Mar 1, 2012 | The Medicines Company, University of Bern |
| NCT01535222 | Phase 2 | Nov 1, 2010 | The Medicines Company, University of Bern |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| The Medicines Company | For profit | 2 | 2 | 1 | 2010 |
| University of Bern | Academic/Hospital | 2 | 0 | 1 | 2010 |
2 organizations
Page 1 / 1